loadpatents
Patent applications and USPTO patent grants for Kraus; Richard J..The latest application filed is for "use of erralpha phosphorylation status as a breast cancer biomarker".
Patent | Date |
---|---|
Method of using estrogen-related receptor alpha (ERR.alpha.) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERR.alpha. as a therapeutic target for the treatment of breast cancer Grant 7,541,141 - Mertz , et al. June 2, 2 | 2009-06-02 |
Use of ERRalpha phosphorylation status as a breast cancer biomarker App 20050118658 - Mertz, Janet E. ;   et al. | 2005-06-02 |
Method of using estrogen-related receptor alpha (ERRalpha) status to determine prognosis, treatment strategy and predisposition to breast cancer, and method of using ERRalpha as a therapeutic target for the treatment of breast cancer App 20030152959 - Mertz, Janet E. ;   et al. | 2003-08-14 |
Portable urinal Grant 4,528,703 - Kraus July 16, 1 | 1985-07-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.